Kither Biotech
Biopharmaceutical company developing novel therapies for rare respiratory diseases
Turin, Italy
Total raised
€19M
€18,500,000
Funding rounds
1
Investors
9
distinct backers
Active since
2022-03
latest 2022-03
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood35
base rate 48% for Series B
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-03-29 | Series B | €19M | 2 Invest,3B Future Health Fund,ACE Ventures,Alef 6,CDP Venture Capital,Claris Ventures+3 more | View deal → |
Investors
9Related news
- Kither Biotech Raises €18.5M in Series B Fundingfinsmes.com · 2022-03
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Bending Spoons€1.7BItaly · Software
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech